Status:

TERMINATED

Noise-Induced Hearing Loss-Acute Exposure Treatment

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

University of Texas

Gateway Biotechnology, Inc.

Conditions:

Hearing Loss, Noise-Induced

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to assess the safety and efficacy of zonisamide for the treatment of noise-induced hearing loss in adults.

Detailed Description

This study is a randomized, double-blinded placebo-control trial with three parallel groups, to make use of a common control group. After being informed about the study expectations and potential risk...

Eligibility Criteria

Inclusion

  • Patients who are scheduled to undergo a skull-based surgery that requires at least 45 minutes of surgical-drilling
  • At least 18 years of age
  • Air conduction thresholds in the non-operated ears are to be no worse than 25 decibel (dB) hearing loss (HL) for pure tone average 0.5, 1, and 2 kilohertz (kHz) with no individual threshold greater than 30 dB HL, and no worse than 45dB HL at 4 kHz at screening.
  • Observed air-bone gap \< 10 dB HL at 0.5, 1, 2, and 4 kHz, with normal tympanometry.
  • Ability to understand and willingness to sign an Institutional Review Board (IRB) approved written informed consent document.

Exclusion

  • History of known sulfa allergy or hypersensitivity to carbonic anhydrase inhibitors
  • History of moderate-to-severe kidney or liver disease
  • Acute viral, bacterial, fungal or parasitic infection
  • History of seizures
  • Currently pregnant or breast-feeding
  • Any current or history of ear disorder and/or central auditory dysfunction in the non-operated ear
  • History of ototoxic drug use
  • Current use of strong/moderate 3A4 inhibitor/inducer and grapefruit juice

Key Trial Info

Start Date :

October 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 29 2023

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04768569

Start Date

October 4 2021

End Date

September 29 2023

Last Update

January 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine

St Louis, Missouri, United States, 63110